# Tranexamic Acid in Nasal Mohs Reconstruction

> **NCT06057675** · PHASE2 · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Postoperative Bleeding
- Skin Cancer Face

## Interventions

- **DRUG:** Treatment (tranexamic acid and 1% lidocaine with 1:100,000 epinephrine)
- **DRUG:** Control (1% lidocaine with 1:100,000 epinephrine)

## Key facts

- **NCT ID:** NCT06057675
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-19
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06057675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06057675, "Tranexamic Acid in Nasal Mohs Reconstruction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06057675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*